Related Experiment Video
Updated: Apr 26, 2026

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
Published on: May 11, 2021
Regenerative medicine: transforming the drug discovery and development paradigm
1Cardiovascular & Metabolic Diseases, Gaithersburg, Maryland 20878.
Abstract:
Despite the explosion of knowledge in basic biological processes controlling tissue regeneration and the growing interest in repairing/replacing diseased tissues and organs through various approaches (e.g., small and large molecule therapeutics, stem cell injection, tissue engineering), the pharmaceutical industry (pharma) has been reluctant to fully adopt these technologies into the traditional drug discovery and research and development (R&D) process. In this article, I discuss knowledge-base gaps and other possible factors that may delay full incorporation of these innovations in pharma R&D. I hope that this discussion will illuminate key issues that currently limit synergistic relationships between pharma and academic institutions and may even stimulate initiation of such collaborative research.
Related Concept Videos
Drug Discovery: Overview
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Whole Body Regeneration
Pharmacogenomics: Identification of New Drug Targets
Microorganisms in Medicine and Therapeutics
EPS and iPS Cells in Disease Research

